EKF Diagnostics (LON:EKF) Shares Up 27.3% - Should You Buy?

EKF Diagnostics Holdings plc (LON:EKF - Get Free Report)'s share price was up 27.3% during mid-day trading on Thursday . The stock traded as high as GBX 26.90 ($0.36) and last traded at GBX 25.20 ($0.34). Approximately 2,253,335 shares changed hands during trading, an increase of 353% from the average daily volume of 497,132 shares. The stock had previously closed at GBX 19.80 ($0.26).

EKF Diagnostics Trading Up 4.4%

The company has a quick ratio of 1.77, a current ratio of 4.60 and a debt-to-equity ratio of 0.34. The firm has a market capitalization of £116.01 million, a PE ratio of 24.29 and a beta of 0.57. The business's fifty day moving average price is GBX 21.44 and its 200 day moving average price is GBX 23.85.

EKF Diagnostics (LON:EKF - Get Free Report) last issued its quarterly earnings results on Tuesday, March 25th. The company reported GBX 1.38 ($0.02) earnings per share for the quarter. EKF Diagnostics had a return on equity of 7.03% and a net margin of 9.37%. As a group, analysts expect that EKF Diagnostics Holdings plc will post 2.2987842 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, insider Gavin T. Jones purchased 50,000 shares of the company's stock in a transaction on Tuesday, March 25th. The stock was bought at an average cost of GBX 22 ($0.29) per share, for a total transaction of £11,000 ($14,692.13). 5.24% of the stock is owned by corporate insiders.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.